Monashee Investment Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-171,193
Closed -$409K 92
2023
Q3
$409K Sell
171,193
-628,591
-79% -$1.39M 0.17% 70
2023
Q2
$1.85M Sell
799,784
-190,077
-19% -$537K 0.44% 40
2023
Q1
$2.52M Sell
989,861
-10,139
-1% -$29K 0.7% 29
2022
Q4
$2.51M Hold
1,000,000
1.08% 28
2022
Q3
$2.9M Buy
1,000,000
+75,000
+8% +$316K 1.08% 12
2022
Q2
$4.18M Buy
925,000
+415,000
+81% +$2.47M 1.52% 3
2022
Q1
$4.09M Sell
510,000
-320,000
-39% -$2.82M 1.18% 8
2021
Q4
$9.66M Sell
830,000
-656,135
-44% -$7.86M 2.39% 3
2021
Q3
$18.4M Buy
+1,486,135
New +$16.8M 3.4% 2

Other funds holding SLGC

Monashee Investment Management's SLGC Position: Q4 2023 in Review

Monashee Investment Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 171,193 shares — an estimated $409K sold.

Monashee Investment Management first reported a position in SLGC in Q3 2021 and held it in 9 quarters. The position peaked at $18.4M in Q3 2021. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Monashee Investment Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Monashee Investment Management sold 171,193 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $409K.
  • Monashee Investment Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 9 quarters.
  • Monashee Investment Management's SomaLogic, Inc. Class A Common Stock position peaked at $18.4M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Monashee Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.